Company History

Founded in 2011 by Dr Richard Weaver, the company has grown from three to almost 40 members of staff in nine years. We have increased our lab and office space and continue to invest in the latest cutting-edge technology, ensuring the best possible service for our global client base. In September 2020, XenoGesis was acquired by Sygnature Discovery.

XenoGesis the name

Our company name, XenoGesis, is derived from two ancient Greek words, xenos (ξένος, foreign) and exegesis (ἐξήγησις, interpretation). The former part, xeno, refers to xenobiotics, i.e. substances foreign to the body such as drug molecules. The latter part, exegesis, stands for the critical review and interpretation of data describing the fate of such compounds in the organism.